EuroEspes S.A (EEP) | Stock Overview & Key Data
EuroEspes S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €2.45 on January 20, 2014
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Annual Income Flow
2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
EuroEspes S.A
EEP
|
6.22M Small-cap | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.85% | -46.53% | -59.70% | -59.70% |
|
Clinica Baviera S.A
CBAV
|
832.96M Mid-cap | -0.38% | 5.69% | 0.00% | 17.65% | 5.48% | 49.86% | 175.86% | 290.98% | 847.18% | 933.80% | 933.80% |
|
Pangaea Oncology
PANG
|
61.77M Small-cap | 1.18% | 1.18% | 2.99% | 1.18% | -0.58% | 3.61% | 17.01% | -25.22% | -31.20% | -31.20% | -31.20% |
|
Grifols, S.A
GRF
|
6.09B Large-cap | -7.25% | 1.24% | -18.49% | -20.87% | -20.02% | 5.17% | -3.97% | -60.31% | -52.89% | 33.98% | 244.23% |
|
Laboratorios
ROVI
|
4.34B Large-cap | -4.70% | 3.25% | 11.63% | 25.93% | 28.02% | 58.55% | 101.84% | 68.26% | 449.09% | 1,459.62% | 743.04% |
|
Almirall S.A
ALM
|
2.76B Large-cap | -0.47% | 11.78% | -0.16% | 0.79% | -1.40% | 31.68% | 36.63% | -2.60% | -9.40% | 65.19% | -15.31% |
Ownership & Short Interest
Calculate Your EuroEspes S.A Investment Returns
Long-Term Investment Performance Analysis
EuroEspes S.A stock price in Jul 2016 was €0.70, A €1,000.00 lump sum investment in EuroEspes S.A made 9 years ago would be worth approximately €771.43 today, representing a negative return of -22.86%. This translates to an annualized return (CAGR) of -2.62%.
9 Years 9 Months Investment Scenario (Jul 2016 - Apr 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EEP's 52-week high and low?
- In the last 52 weeks, EuroEspes S.A reached a high of €0.54 (on April 24, 2026) and a low of €0.54 (on April 24, 2026).
- What is the market cap and P/E ratio for EEP?
- Curious about EuroEspes S.A's size and valuation? Its market capitalization stands at 6.22M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is N/A.
- Does EEP pay dividends? If so, what's the yield?
- As for dividends, EuroEspes S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are EuroEspes S.A's main competitors or similar companies to consider before investing?
When looking at EuroEspes S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Clinica Baviera S.A
CBAV832.96M Healthcare Diagnostics & Research 49.86% 175.86% Pangaea Oncology
PANG61.77M Healthcare Diagnostics & Research 3.61% 17.01% Grifols, S.A
GRF6.09B Healthcare Drug Manufacturers - General 5.17% -3.97% Laboratorios
ROVI4.34B Healthcare Drug Manufacturers - Specialty & Generic 58.55% 101.84% Almirall S.A
ALM2.76B Healthcare Drug Manufacturers - Specialty & Generic 31.68% 36.63% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for EuroEspes S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of EuroEspes S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -12.57%, the Debt to Equity ratio from the most recent quarter is 0.70, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for EEP?
- Looking at EuroEspes S.A's growth, its revenue over the trailing twelve months (TTM) was €3M. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of EEP stock is held by insiders and institutions?
- Wondering who owns EuroEspes S.A stock? Company insiders (like executives and directors) hold about N/A of the shares, while institutional investors (such as mutual funds and pension funds) own approximately N/A.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.